Deucracitinib

Brevis descriptio:

API Nomen Indicium Innovator Exitus patentibus Date (US)
Deucracitinib Anti plaque psoriasis Bristol-Myers Squibb Company Nov.07,2033


Product Detail

Product Tags


  • Priora:
  • Next:

  • Epistulam tuam hic scribe et mitte nobis